Pneumococcal 21-valent Conjugate Vaccine

CHEBI:CHEBI_749939

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
route
INTRAMUSCULAR
dosage_form
INJECTION, SOLUTION
product_type
LICENSED VACCINE BULK INTERMEDIATE
marketing_category
DRUG FOR FURTHER PROCESSING
pharm_class
Pneumococcal Vaccines [CS]
marketing_start_date
20240617
package_marketing_start_date
17-JUN-24
labeler_name
MSD Ireland (Carlow)
active_ingredient_name
STREPTOCOCCUS PNEUMONIAE TYPE DEOAC15B CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN
generic_name
Pneumococcal 21-valent Conjugate Vaccine
product_ndc
0006-4347
spl_id
2b72eccd-646e-4b46-b08e-fb9b78e85f11
active_ingredient_strength
4 ug/.5mL
package_ndc
0006-4347-02
package_description
10 SYRINGE in 1 CARTON (0006-4347-02) / .5 mL in 1 SYRINGE (0006-4347-99)
brand_name
CAPVAXIVE
brand_name_base
CAPVAXIVE
application_number
BLA125814
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class